Aberrant Expression of Epithelial-Mesenchymal Transition Markers in Early Gastric Cancer: Clinical Application

참고문헌 (Reference)

1 방창석, "Therapeutic Outcomes of Endoscopic Resection of Early Gastric Cancer with Undifferentiated-Type Histology: A Korean ESD Registry Database Analysis" 대한소화기내시경학회 50 (50): 569-577, 2017

2 Herrero R, "The fight against gastric cancer-the IARC Working Group report" 28 : 1107-1114, 2014

3 Cho SY, "Sporadic early-onset diffuse gastric cancers have high frequency of somatic CDH1 alterations, but low frequency of somatic RHOA mutations compared with late-onset cancers" 153 : 536-549, 2017

4 Peng Z, "Role of epithelial-mesenchymal transition in gastric cancer initiation and progression" 20 : 5403-5410, 2014

5 Chen HC, "Loss of E-cadherin expression correlates with poor differentiation and invasion into adjacent organs in gastric adenocarcinomas" 201 : 97-106, 2003

6 Gotoda T, "Incidence of lymph node metastasis from early gastric cancer : estimation with a large number of cases at two large centers" 3 : 219-225, 2000

7 Hee Jae Jung, "Immunohistochemical Expression of Epithelial-Mesenchymal Transition Markers in Early Gastric Cancer: Cancer Tissue versus Noncancer Tissue" 대한소화기내시경학회 52 (52): 464-471, 2019

8 Ono H, "Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer" 28 : 3-15, 2016

9 Kim SH, "Arsenic trioxide attenuates STAT-3 activity and epithelial-mesenchymal transition through induction of SHP-1 in gastric cancer cells" 18 : 150-, 2018